US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist
  • 3.1600
  • +0.1000+3.27%
Trading Mar 18 14:17 ET
4.74MMarket Cap0.00P/E (TTM)

CNS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CNS Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q30.000 / 0.000--

Unlock Free Earnings Estimates

CNS Pharmaceuticals Earnings Reports

  • CNS Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 17:07 ET

  • CNS Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 17:26 ET

  • CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports First Quarter 2024 Financial Results Enrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025

    May 16, 2024 11:01 ET

  • CNS Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 15, 2024 17:06 ET

    • Read more

    Trending Stocks

    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    No. Symbol Price
    Dorian LPG
    LPG
    22.720
    YETI Holdings
    YETI
    34.415
    Lantheus
    LNTH
    103.400
    4
    Teradata Corp
    TDC
    23.340
    5
    Workday
    WDAY
    250.665
    Log In for the Full List
    Unlock Now
    Investment Course
    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
    Discussing
    Fed’s March rate decision nears: Market pivot ahead?
    How will the Fed's rate decision impact short-term trends in U.S. stocks? How would you reposition your portfolio? Show More
    FOMC Press Conference, January 29, 2025